Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.
Marina SerperDonna M EvonJipcy AmadorPaul W StewartSouvik SarkarAnna S LokRichard K SterlingBryce B ReeveCarol E GolinK Rajender ReddyJoseph K LimNancy S ReauDavid R NelsonAdrian M Di BisceglieMichael W FriedPublished in: Liver international : official journal of the International Association for the Study of the Liver (2021)
The improvements in patient-reported outcomes reported by patients who achieved SVR following HCV DAA therapy were durable at 12 months post-treatment.